We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$856M
Cap. Flow %
-14.88%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170
Avg Time Held Equity + Options
1.1 quarters
Top 10 Avg Time Held Equity + Options
1.6 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
1.1 quarters
Top 10 Avg Time Held Equity only
1.6 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.33%
2 Consumer Discretionary 12.63%
3 Healthcare 11.94%
4 Industrials 11.3%
5 Consumer Staples 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BRCD
501
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$292K 0.01%
24,627
-181,526
-88% -$1.97M
2014 Q3
1 quarter
LITS icon
502
Lite Strategy Inc
LITS
$38.6M
$287K 0.01%
+3,355
New +$442K
2014 Q4
0 quarters
ON icon
503
ON Semiconductor
ON
$30.2B
$287K 0.01%
28,307
+16,435
+138% +$144K
2014 Q2
2 quarters
STJ
504
DELISTED
St Jude Medical
STJ
$280K ﹤0.01%
+4,306
New +$277K
2014 Q4
0 quarters
WWAV
505
CALL
DELISTED
The WhiteWave Foods Company
WWAV
$279K ﹤0.01%
+100,600
New +$3.57M
2014 Q4
0 quarters
EHC icon
506
Encompass Health
EHC
$12.2B
$277K ﹤0.01%
+9,060
New +$282K
2014 Q4
0 quarters
NTBL icon
507
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$277K ﹤0.01%
+1,338
New +$289K
2014 Q4
0 quarters
VIAB
508
DELISTED
Viacom Inc. Class B
VIAB
$276K ﹤0.01%
3,663
-5,261
-59% -$385K
2013 Q3
5 quarters
BHE icon
509
Benchmark Electronics
BHE
$2.93B
$275K ﹤0.01%
+10,791
New +$253K
2014 Q4
0 quarters
OCGN icon
510
Ocugen
OCGN
$324M
$275K ﹤0.01%
+417
New +$275K
2014 Q4
0 quarters
CAA
511
DELISTED
CalAtlantic Group, Inc.
CAA
$274K ﹤0.01%
7,525
+5,150
+217% +$191K
2014 Q3
1 quarter
LXK
512
DELISTED
Lexmark Intl Inc
LXK
$273K ﹤0.01%
+6,617
New +$275K
2014 Q4
0 quarters
AES icon
513
AES
AES
$10.7B
$267K ﹤0.01%
+19,381
New +$265K
2014 Q4
0 quarters
OGE icon
514
OGE Energy
OGE
$9.61B
$266K ﹤0.01%
+7,509
New +$271K
2014 Q4
0 quarters
IVZ icon
515
Invesco
IVZ
$13B
$265K ﹤0.01%
6,704
-95,815
-93% -$3.78M
2014 Q3
1 quarter
TMH icon
516
DELISTED
Team Health Holdings Inc
TMH
$264K ﹤0.01%
+4,588
New +$264K
2014 Q4
0 quarters
NFG icon
517
National Fuel Gas
NFG
$7.48B
$263K ﹤0.01%
+3,776
New +$261K
2014 Q4
0 quarters
TUP icon
518
DELISTED
Tupperware Brands Corporation
TUP
$263K ﹤0.01%
+4,174
New +$273K
2014 Q4
0 quarters
THG icon
519
Hanover Insurance
THG
$7.64B
$257K ﹤0.01%
+3,599
New +$243K
2014 Q4
0 quarters
HT
520
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$257K ﹤0.01%
9,141
+4,341
+90% +$123K
2014 Q2
2 quarters
HTS
521
DELISTED
HATTERAS FINANCIAL CORP
HTS
$257K ﹤0.01%
+13,937
New +$263K
2014 Q4
0 quarters
UHS icon
522
Universal Health Services
UHS
$10.5B
$256K ﹤0.01%
+2,300
New +$242K
2014 Q4
0 quarters
UNH icon
523
UnitedHealth
UNH
$340B
$255K ﹤0.01%
+2,527
New +$239K
2014 Q4
0 quarters
CBT icon
524
Cabot Corp
CBT
$3.87B
$254K ﹤0.01%
+5,799
New +$262K
2014 Q4
0 quarters
BRLI
525
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$253K ﹤0.01%
+7,883
New +$228K
2014 Q4
0 quarters

Similar funds

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $856M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.